126 related articles for article (PubMed ID: 26517356)
1. Combined 3D-QSAR and Molecular Docking Study for Identification of Diverse Natural Products as Potent Pf ENR Inhibitors.
Wadhwa P; Saha D; Sharma A
Curr Comput Aided Drug Des; 2015; 11(3):245-57. PubMed ID: 26517356
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors.
Shah P; Siddiqi MI
SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.
Morde VA; Shaikh MS; Pissurlenkar RR; Coutinho EC
Mol Divers; 2009 Nov; 13(4):501-17. PubMed ID: 19347595
[TBL] [Abstract][Full Text] [Related]
6. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
[TBL] [Abstract][Full Text] [Related]
7. Identification of PfENR inhibitors: A hybrid structure-based approach in conjunction with molecular dynamics simulations.
Manhas A; Patel A; Lone MY; Jha PK; Jha PC
J Cell Biochem; 2018 Nov; 119(10):8490-8500. PubMed ID: 30105881
[TBL] [Abstract][Full Text] [Related]
8. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
Kumar SP; George LB; Jasrai YT; Pandya HA
SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, structural characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors.
Samal RP; Khedkar VM; Pissurlenkar RR; Bwalya AG; Tasdemir D; Joshi RA; Rajamohanan PR; Puranik VG; Coutinho EC
Chem Biol Drug Des; 2013 Jun; 81(6):715-29. PubMed ID: 23398677
[TBL] [Abstract][Full Text] [Related]
10. Identification of natural products against enoyl-acyl-carrier-protein reductase in malaria via combined pharmacophore modeling, molecular docking and simulations studies.
Manhas A; Ghosh A; Verma Y; Das T; Jha PC
J Biomol Struct Dyn; 2023 Mar; 41(5):2002-2015. PubMed ID: 35043754
[No Abstract] [Full Text] [Related]
11. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
Kumari M; Chandra S; Tiwari N; Subbarao N
BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
[TBL] [Abstract][Full Text] [Related]
14. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A
J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
16. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
Frecer V; Megnassan E; Miertus S
Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A
J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517
[TBL] [Abstract][Full Text] [Related]
18. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
19. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore and molecular docking guided 3D-QSAR study of bacterial enoyl-ACP reductase (FabI) Inhibitors.
Lu X; Lv M; Huang K; Ding K; You Q
Int J Mol Sci; 2012; 13(6):6620-6638. PubMed ID: 22837653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]